A 28-year-old woman with moderate-to-severe atopic dermatitis affecting >30% body surface area, unresponsive to optimized topical corticosteroids and emollients over 8 weeks, presents for systemic therapy. She has no contraindications to immunosuppression. What is the preferred first-line systemic agent according to current guidelines?